VasoMedical, Inc. announces the successful launch of the ARCS2020 Cloud, a cloud version of its proprietary Holter and ABPM analysis and reporting software ARCS2020, in the United States and China, with additional services expected to be coming soon in Europe and other locations around the world.
VasoMedical and its wholly owned subsidiary, Biox Instruments, have supported its ECG and ABPM analysis and reporting software for many years, and in 2015 began the evolution of ARCS -Analysis, Reporting and Communication Software. Today, this widely used cardiology software package is an accurate and much utilized tool with approximately 3,300 ARCS licenses in use worldwide, and COVID-19 pandemic has made ARCS2020 Cloud an even more valuable tool for those IDTF centers and ECG technicians working remotely. We expect this trend to continue as it has changed the way we all work, reducing the need for dedicated office space.
With the launch of ARCS2020 Cloud, VasoMedical is entering the rapidly growing business of SaaS (software as a service) for healthcare provision. Compared to PC-based stand-alone software, ARCS2020 Cloud provides many additional advantages, including: